| ISIN | CH0368190739 |
|---|---|
| Valor Number | 36819073 |
| Bloomberg Global ID | CHSRI SW |
| Fund Name | UBS ETF (CH) - UBS MSCI Switzerland IMI Socially Responsible ETF CHF dis |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Asset Allocation |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | n/a |
| Peculiarities |
| Current Price * | 18.90 CHF | 18.12.2025 |
|---|---|---|
| Previous Price * | 18.72 CHF | 17.12.2025 |
| 52 Week High * | 18.90 CHF | 18.12.2025 |
| 52 Week Low * | 15.66 CHF | 09.04.2025 |
| NAV * | 18.90 CHF | 18.12.2025 |
| Issue Price * | 18.90 CHF | 18.12.2025 |
| Redemption Price * | 18.90 CHF | 18.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 540,807,501 | |
| Unit/Share Assets *** | 269,403,772 | |
| Trading Information SIX | ||
| YTD Performance | +11.09% |
31.12.2024 - 18.12.2025
31.12.2024 18.12.2025 |
|---|---|---|
| 1 month | +4.69% |
18.11.2025 - 18.12.2025
18.11.2025 18.12.2025 |
| 3 months | +4.88% |
18.09.2025 - 18.12.2025
18.09.2025 18.12.2025 |
| 6 months | +4.74% |
18.06.2025 - 18.12.2025
18.06.2025 18.12.2025 |
| 1 year | +10.78% |
18.12.2024 - 18.12.2025
18.12.2024 18.12.2025 |
| 2 years | +20.62% |
18.12.2023 - 18.12.2025
18.12.2023 18.12.2025 |
| 3 years | +34.54% |
19.12.2022 - 18.12.2025
19.12.2022 18.12.2025 |
| 5 years | +36.46% |
18.12.2020 - 18.12.2025
18.12.2020 18.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 11.27% | |
|---|---|---|
| UBS Group AG Registered Shares | 10.98% | |
| ABB Ltd | 10.43% | |
| Novartis AG Registered Shares | 10.41% | |
| Zurich Insurance Group AG | 10.39% | |
| Nestle SA | 9.83% | |
| Alcon Inc | 9.73% | |
| Lonza Group Ltd | 9.59% | |
| Givaudan SA | 8.88% | |
| Swiss Re AG | 8.74% | |
| Last data update | 15.12.2025 | |
| TER | 0.28% |
|---|---|
| TER date | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.60% |
| Ongoing Charges *** | 0.28% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |